Insights on chronic hypersensitivity pneumonitis' treatment: Factors associated with a favourable response to azathioprine

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Oksana Sokhatska

    Autor

  • Hélder Novais E Bastos

    Autor

Participantes de fora da FMUP

  • Raimundo, S
  • Pimenta, AC
  • Cruz Martins, N.
  • Rodrigues, MC
  • Melo, N
  • Mota, P.
  • Beltrao, M
  • Guimaraes, S
  • Moura, M.
  • Cunha, R.
  • Pereira, JM
  • Morais, A

Unidades de investigação

Abstract

Background: The use of immunosuppressive and antifibrotic agents for the treatment of chronic hypersensitivity pneumonitis (CHP) appears promising, but there is still no evidence supporting the clinical decision regarding the implementation of each specific pharmacological strategy. Methods: Patients diagnosed with CHP and treated with azathioprine (AZA) were retrospectively selected from a single centre for Interstitial Lung Diseases. Baseline clinical data, as well as functional, imaging, bronchoalveolar lavage (BAL) and histology features were assessed. Longitudinal data on functional parameters were collected and comparatively analysed with patients' characteristics. Results: In this cohort of 80 patients, of those who reached 12 months of treatment, 78.3% presented a preserved forced vital capacity, with 59 being eligible to be classified as AZA responders (n = 36) or non-responders (n = 23). BAL lymphocytosis was associated with a favourable response to AZA treatment (OR 1.051; 95% CI 1.015-1.089), although it didn't identify all responders. Conclusions: AZA revealed to be effective in disease stabilisation in most patients, while ineffective for a subset. BAL lymphocytosis appears as a potentially valuable strategy to identify AZA responders, although with limited accuracy. Further studies are needed to clarify other response markers to immunosuppressive agents, in order to optimize the therapeutic options for this condition.

Dados da publicação

ISSN/ISSNe:
1879-0631, 0024-3205

Life Sciences  Elsevier Inc.

Tipo:
Article
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 9

Citações Recebidas na Scopus: 10

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Azathioprine; Bronchoalveolar lavage; Extrinsic allergic alveolitis; Immunosuppression; Interstitial lung diseases; Hypersensitivity Pneumonitis

Financiamento

Proyectos asociados

Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2020

Non-invasive assessment of Benign Tracheal Stenosis.

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação